T. Rowe Price Investment Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$110M Buy
6,878,956
+984,132
+17% +$15.7M 0.07% 262
2025
Q1
$101M Buy
5,894,824
+777,590
+15% +$13.3M 0.07% 280
2024
Q4
$127M Buy
5,117,234
+1,786,217
+54% +$44.2M 0.08% 247
2024
Q3
$95M Buy
3,331,017
+1,705,797
+105% +$48.6M 0.06% 305
2024
Q2
$42.9M Buy
+1,625,220
New +$42.9M 0.03% 406